Anemia, a prevalent health concern globally, arises from low hemoglobin levels, often resulting in debilitating symptoms such ...
Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
Chronic anemia can leave you feeling tired, weak, and unable to concentrate. It happens when your body doesn’t have enough ...
KDOQI (2007) KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50: 471–530 National ...
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 g/dL for the ...
The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.